Sabino De Placido
Sabino De Placido
Professore Ordinario di Oncologia Medica
Verified email at unina.it
TitleCited byYear
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
45012005
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of The Liver
Journal of hepatology 56 (4), 908-943, 2012
33702012
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor
F Ciardiello, R Caputo, R Bianco, V Damiano, G Pomatico, S De Placido, ...
Clinical Cancer Research 6 (5), 2053-2063, 2000
11812000
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor
F Ciardiello, R Caputo, R Bianco, V Damiano, G Fontanini, S Cuccato, ...
Clinical cancer research 7 (5), 1459-1465, 2001
7522001
c-erbB2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, ...
Journal of Clinical Oncology 14, 2702-2708, 1996
5201996
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer
G Di Lorenzo, G Tortora, FP D’Armiento, G De Rosa, S Staibano, ...
Clinical Cancer Research 8 (11), 3438-3444, 2002
5042002
Estrogen receptor–positive, progesterone receptor–negative breast cancer: association with growth factor receptor expression and tamoxifen resistance
G Arpino, H Weiss, AV Lee, R Schiff, S De Placido, CK Osborne, ...
Journal of the National Cancer Institute 97 (17), 1254-1261, 2005
4922005
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense …
F Ciardiello, R Bianco, V Damiano, G Fontanini, R Caputo, G Pomatico, ...
Clinical Cancer Research 6 (9), 3739-3747, 2000
4912000
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials
M De Laurentiis, G Cancello, D D'Agostino, M Giuliano, A Giordano, ...
Journal of Clinical Oncology 26 (1), 44-53, 2008
4212008
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225
F Ciardiello, R Bianco, V Damiano, S De Lorenzo, S Pepe, S De Placido, ...
Clinical Cancer Research 5 (4), 909-916, 1999
4011999
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth …
F Ciardiello, R Bianco, R Caputo, R Caputo, V Damiano, T Troiani, ...
Clinical Cancer Research 10 (2), 784-793, 2004
3722004
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study
G Fontanini, S Vignati, F Basolo, G Bevilacqua, M Lucchi, A Mussi, ...
Journal of the National Cancer Institute 89 (12), 881-886, 1997
3661997
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
M De Laurentiis, G Arpino, E Massarelli, A Ruggiero, C Carlomagno, ...
Clinical cancer research 11 (13), 4741-4748, 2005
3612005
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin …
G Fontanini, M De Laurentiis, S Vignati, S Chinč, M Lucchi, V Silvestri, ...
Clinical Cancer Research 4 (1), 241-249, 1998
3481998
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
F De Vita, M Orditura, E Matano, R Bianco, C Carlomagno, S Infusino, ...
British journal of cancer 92 (9), 1644, 2005
3082005
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients
Cancer of the Liver Italian Program (CLIP) Investigators
Hepatology 28 (3), 751-755, 1998
2651998
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
S Pignata, G Scambia, D Katsaros, C Gallo, E Pujade-Lauraine, ...
The Lancet Oncology 15 (4), 396-405, 2014
2102014
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer
R Lauria, F Perrone, C Carlomagno, M De Laurentiis, A Morabito, C Gallo, ...
Cancer 76 (10), 1772-1778, 1995
2071995
Treatment of human epidermal growth factor receptor 2–overexpressing breast cancer xenografts with multiagent HER-targeted therapy
G Arpino, C Gutierrez, H Weiss, M Rimawi, S Massarweh, L Bharwani, ...
Journal of the National Cancer Institute 99 (9), 694-705, 2007
1912007
Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis
S De, R Autorino, FJ Kim, H Zargar, H Laydner, R Balsamo, FC Torricelli, ...
European urology 67 (1), 125-137, 2015
1902015
The system can't perform the operation now. Try again later.
Articles 1–20